skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines mavacamtenQuestion & answer

mavacamten · Medicine question

Who is mavacamten licensed to treat in the UK?

iatroX medicinesPublished 21 August 2026Reviewed 21 August 2026

The answer

Answer

It is licensed for adults with symptomatic obstructive hypertrophic cardiomyopathy classified as NYHA class II or III.

Sources for this answer

Mavacamten BMS 2.5 mg, 5 mg, 10 mg, 15 mg hard capsulesemc · SmPC Current selected SmPC · Version 6

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

mavacamten

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the mavacamten guide

More questions about mavacamten

Why is a CYP2C19 genetic test needed before mavacamten?Why are echocardiograms needed with mavacamten?Can mavacamten capsules be opened or crushed?Can mavacamten be taken with food?Can I take omeprazole while using mavacamten?Can mavacamten be taken during pregnancy?

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX